Cargando…
Plasma Midregional Pro-Adrenomedullin Improves Prediction of Functional Outcome in Ischemic Stroke
BACKGROUND: To evaluate if plasma levels of midregional pro-adrenomedullin (MR-proADM) improve prediction of functional outcome in ischemic stroke. METHODS: In 168 consecutive ischemic stroke patients, plasma levels of MR-proADM were measured within 24 hours from symptom onset. Functional outcome wa...
Autores principales: | Seifert-Held, Thomas, Pekar, Thomas, Gattringer, Thomas, Simmet, Nicole E., Scharnagl, Hubert, Bocksrucker, Christoph, Lampl, Christian, Storch, Maria K., Stojakovic, Tatjana, Fazekas, Franz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3718829/ https://www.ncbi.nlm.nih.gov/pubmed/23894342 http://dx.doi.org/10.1371/journal.pone.0068768 |
Ejemplares similares
-
Midregional pro-Adrenomedullin in addition to b-type natriuretic peptides in the risk stratification of patients with acute dyspnea: an observational study
por: Potocki, Mihael, et al.
Publicado: (2009) -
Lipocalin-2 as an Infection-Related Biomarker to Predict Clinical Outcome in Ischemic Stroke
por: Hochmeister, Sonja, et al.
Publicado: (2016) -
Serum netrin-1 in relation to gadolinium-enhanced magnetic resonance imaging in early multiple sclerosis
por: Voortman, MM, et al.
Publicado: (2017) -
Plasma mid‐regional pro‐adrenomedullin: A biomarker of the ischemic penumbra in hyperacute stroke
por: Ishiyama, Hiroyuki, et al.
Publicado: (2022) -
Midregional pro atrial natriuretic peptide: a novel important biomarker for noise annoyance-induced cardiovascular morbidity and mortality?
por: Hahad, Omar, et al.
Publicado: (2020)